Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reference values for leptin/adiponectin ratio in healthy children and adolescents

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical proteomics: Insights from IGF-I

    Research output: Contribution to journalReviewpeer-review

  4. Validation of image cytometry for sperm concentration measurement: Comparison with manual counting of 4010 human semen samples

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Clinical usefulness of bone turnover marker concentrations in osteoporosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • IFCC-IOF Committee for Bone Metabolism
View graph of relations

Procollagen type I N-propeptide (PINP) and the C-terminal telopeptide of type I collagen (β-CTX) in blood have been designated as reference bone turnover markers in osteoporosis by the International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The IFCC Committee on Bone Metabolism (C-BM) has examined current commercial assays and performed a multicentre study to examine the agreement between assays for PINP and β-CTX in serum and plasma. The results of these studies will inform our work towards the harmonization of PINP assays and the standardization of β-CTX assays in blood, with the development of common calibrators and reference measurement procedures in collaboration with the reagent manufacturing industry. Successful achievement of these goals will help develop universally acceptable practice guidelines for the management of osteoporosis with the inclusion of common reference intervals and treatment targets for PINP and β-CTX.

Original languageEnglish
JournalClinica chimica acta; international journal of clinical chemistry
Volume515
Pages (from-to)16-20
Number of pages5
ISSN0009-8981
DOIs
Publication statusPublished - Apr 2021

ID: 64127535